Monday 18th January 2021 GatewayC have produced a list of cancer charity support lines for people who may be worried about their cancer diagnosis, or are concerned about how COVID-19 might affect their cancer treatment. Please download this PDF resource or find the...
15th January 2021 Missed our free GatewayC webinar on Diagnosing Ovarian Cancer? Watch our recording here. In this webinar, GatewayC met Professor Gordon Jayson, Professor of Medical Oncology at The Christie NHS Foundation Trust, who answered key questions from our...
Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...
Potential pitfall: In the early course of the disease, pancreatic cancer may not cause any signs or symptoms. However, sudden onset diabetes in groups of patients for whom this would be unexpected can be an early indicator. Helpful hint: NICE NG12 guidelines recommend...
Leukaemia is a cancer that begins in the bone marrow, leading to the over production of white blood cells. This can negatively affect the blood’s platelet count and in turn, impact the blood’s ability to clot.
Many of us experience bruising, with presentation common in groups such as the elderly population (with thinner skin and more fragile tissue), or active young adults or children playing regular sport. However, patients presenting with bruising without a clear cause should be reason for further consideration.
A reduced platelet count caused by leukaemia can reduce a patient’s clotting ability. As a result, they may present with unexplained bruising.
NICE NG12 guidelines advise consider a very urgent full blood count (within 48 hours) to assess for leukaemia in children, young people or adults with unexplained bruising or bleeding.
Download this Cancer Key here.
Access GatewayC’s course on early diagnosis of chronic leukaemia here.